Amrize's undervalued outlook faces Wall Street caution despite attractive valuation signals

Despite a 14.3% decline in 2026 and several undervaluation metrics, Amrize’s shares remain under pressure amid cautious analyst sentiment and margin concerns, prompting investors to weigh potential opportunities against operational risks. Amrize’s shares have been under pressure this year, but…















